Fresenius Kabi launches IV Drug in the U.S.

Romidepsin Injection, a drug used to treat cutaneous T-cell lymphoma (CTCL) in adults, is now available from Fresenius Kabi in the United States. This is the newest addition to the company’s portfolio of generic IV oncology products - the largest such portfolio in the U.S.